Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial

AIMS/HYPOTHESIS: Previous studies have suggested that the haemoglobin glycation index (HGI) can be used as a predictor of diabetes-related complications in individuals with type 1 and type 2 diabetes. We investigated whether HGI was a predictor of adverse outcomes of intensive glucose lowering and o...

Descripción completa

Detalles Bibliográficos
Autores principales: van Steen, Sigrid C., Woodward, Mark, Chalmers, John, Li, Qiang, Marre, Michel, Cooper, Mark E., Hamet, Pavel, Mancia, Giuseppe, Colagiuri, Stephen, Williams, Bryan, Grobbee, Diederick E., DeVries, J. Hans
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448976/
https://www.ncbi.nlm.nih.gov/pubmed/29308539
http://dx.doi.org/10.1007/s00125-017-4539-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448976/
https://www.ncbi.nlm.nih.gov/pubmed/29308539
http://dx.doi.org/10.1007/s00125-017-4539-1

Ejemplares similares